Alexandria Real Estate Equities enters the final stretch before its July 20 Q2 results with short sellers accelerating positions and a founder doubling down with his own money — a rare and pointed divergence in the same name.
The short interest story is the sharpest signal this week. Short interest has nearly doubled in the past month, jumping 39% in the last week alone to reach 5.2% of the free float — roughly 9 million shares as of June 30. That's a meaningful build for a REIT, and the speed matters: this is the highest short interest reading in the available history, up from a stable band near 6.3–7.4 million shares through most of May and early June. Despite that rapid accumulation, the borrow market remains extraordinarily loose. Availability is running at over 1,200% — meaning there are more than twelve times as many shares available to lend as are already borrowed — and cost to borrow is just 0.40%, down from an already-modest 0.47% a week ago. The lending pool is showing no strain whatsoever, which means the new shorts are stepping into a frictionless setup. There is no squeeze pressure here.
Options positioning offers mild additional caution. The put/call ratio edged up to 1.18 on June 30, slightly above its 20-day average of 1.15 — a z-score of just 0.32, firmly within normal range. Notably, the PCR has been drifting lower since mid-May, when it regularly printed above 1.35, suggesting options traders have actually been reducing their hedges even as short sellers build. The ORTEX short score climbed from around 36-37 in mid-June to 44.0 by June 30, its highest reading of the tracked period, consistent with the spike in short interest.
The Street is divided, and the fault lines are clear. Morgan Stanley moved to Underweight on June 11, the most bearish action from a major house in recent months, keeping its $53 target unchanged. The bear case centres on rising tenant move-outs, asset sales needed to fund the development pipeline, and a projected 28% drop in core earnings in 2026. Evercore ISI Group pushed back this week — on July 1, Steve Sakwa raised his target from $58 to $60 while maintaining Outperform — making him the most explicitly bullish voice on the Street right now, with the stock trading at $52.85. The mean analyst target is $52, essentially flat with the current price, which frames the consensus as roughly fairly valued rather than offering any meaningful uplift. The P/E multiple at 352x reflects near-zero GAAP earnings, while EV/EBITDA near 16x has ticked up modestly over 30 days. The ORTEX factor score for forward EPS momentum ranks in just the 1st percentile — the weakest possible reading — while the 12-month forward EPS year-on-year improvement scores at the 72nd percentile, suggesting analysts see better numbers ahead even if near-term estimates keep getting cut.
The insider tape is the clearest contrarian signal in the data. Founder and Executive Chairman Joel Marcus purchased roughly 25,000 shares across four separate transactions between May 4 and May 6, at prices ranging from $41.02 to $46.74, spending approximately $838,000 of his own capital. The CTO also bought 3,500 shares at $41 on April 30. Since then, the CFO sold a modest $108,000 worth on June 9 and the CEO trimmed a small routine position — but net insider activity over the past 90 days is positive at roughly $2.25 million. The founder buying in size at multi-year lows, right after the stock fell nearly 15% on the April 28 earnings print, is a meaningful signal. Those shares are now up roughly 25% from Marcus's average entry near $43-47.
The earnings history underscores why caution is warranted into July 20. The April 28 Q1 release saw the stock fall 14.7% on the day and 13.2% over the following five days — one of the sharper single-session drops for a large REIT in recent memory. The October 2025 print produced a smaller 1.7% drop. Two consecutive negative reactions set a defensive backdrop for the next release, and the combination of accelerating short interest, a Morgan Stanley Underweight, and the weakest EPS momentum ranking in the factor universe suggests the bar is low but the bears are not done positioning.
The next three weeks reduce to a single question: whether Alexandria's guidance on occupancy trends and the development pipeline, due July 20, gives the Evercore bulls or the Morgan Stanley bears the better-supported story.
See the live data behind this article on ORTEX.
Open ARE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
